General Medicine and Primary Care - Prova Education

Episodes 17-32 of 128

Is Gout Hiding in the Nephrology Clinic?
Is Gout Hiding in the Nephrology Clinic?
MinuteCE®
Is Gout Hiding in the Nephrology Clinic?
- Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®
Center of the Target: Which Patients Are Most Likely to Develop Gout?
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
Treat or Refer: Who Is Responsible for Managing Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®
Treat or Refer: Who Is Responsible for Managing Gout?
- John K. Botson, MD, RPh
- Abdul Abdellatif, MD, FASN
Is Managing Gout in the Nephrology Clinic a Challenge?
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®
Is Managing Gout in the Nephrology Clinic a Challenge?
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
What’s New About Gout? Rheumatology Perspective
What’s New About Gout? Rheumatology Perspective
MinuteCE®
What’s New About Gout? Rheumatology Perspective
- Richard Johnson, MD
- John K. Botson, MD, RPh
Gout Beyond the Joints: What’s the Hidden Danger?
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®
Gout Beyond the Joints: What’s the Hidden Danger?
- Richard Johnson, MD
Should We Look for Gout in the Cardiology Clinic?
Should We Look for Gout in the Cardiology Clinic?
MinuteCE®
Should We Look for Gout in the Cardiology Clinic?
- Richard Johnson, MD
- Brittany Weber, MD, PhD
What Are the Emerging Therapies for Managing Gout?
What Are the Emerging Therapies for Managing Gout?
MinuteCE®
What Are the Emerging Therapies for Managing Gout?
- Richard Johnson, MD
- John K. Botson, MD, RPh
MinuteCE®
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
- Brittany Weber, MD, PhD
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
CME/CE
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
- Mazen Noureddin, MD, MHSc
Selecting an AUD Treatment: Acamprosate
Selecting an AUD Treatment: Acamprosate
MinuteCE®
Selecting an AUD Treatment: Acamprosate
- Edwin A. Salsitz, MD, DFASAM
- Ethan A. Cowan, MD
Selecting an AUD Treatment: Off-Label Agents
Selecting an AUD Treatment: Off-Label Agents
MinuteCE®
Selecting an AUD Treatment: Off-Label Agents
- Ethan A. Cowan, MD
- Edwin A. Salsitz, MD, DFASAM
How, When, and Why to Conduct Brief AUD Interventions
How, When, and Why to Conduct Brief AUD Interventions
MinuteCE®
How, When, and Why to Conduct Brief AUD Interventions
- Edwin A. Salsitz, MD, DFASAM
Selecting an AUD Treatment: Disulfiram
Selecting an AUD Treatment: Disulfiram
MinuteCE®
Selecting an AUD Treatment: Disulfiram
- Edwin A. Salsitz, MD, DFASAM
- Ethan A. Cowan, MD
Assessing a Patient’s Willingness to Accept Treatment for AUD
Assessing a Patient’s Willingness to Accept Treatment for AUD
MinuteCE®
Assessing a Patient’s Willingness to Accept Treatment for AUD
- Edwin A. Salsitz, MD, DFASAM
Case-Based AUD Challenge
Case-Based AUD Challenge
MinuteCE®
Case-Based AUD Challenge
- Annie Levesque, MD, MSc
- Edwin A. Salsitz, MD, DFASAM

2/7